Defence stocks witnessed a rally despite a dim market sentiment, adding over 1% in Nifty India Defence index. This marks a third straight session of gains.
The quarterly EBITDA of the company has reached ₹1,791 crore, with a 12.5% year-on-year growth due to stable operating activities and maintained cost efficiency.
Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.
The Day-Ahead Contingency and Term-Ahead Market (TAM), posted a volume of 1,684 MU, higher by 38% against 1,221 MU in May 2024.
Last week, the company secured another contract worth ₹140 Crore for making multi-purpose wagons.
Wipro also stated that it will provide Gen-AI powered products to restructure self-service, resulting in better user experiences.
Harris added that in FY26, the company’s performance will depend on macroeconomic factors and the extent of clarity achieved.
Top gainers in the Indian Benchmark Index Sensex include Eternal, Bharti Airtel, Tech Mahindra, IndusInd Bank
The NFO is available for subscription from June 02 to June 16, 2025.
The NFO is available for subscription from June 02 to June 16, 2025.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
